Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,630.09
(
0.08%
)
US TECH 100
23,617.80
(
-0.75%
)
Dow Jones
46,217.69
(
-0.02%
)
Brent Oil
101.71
(
-4.57%
)
Bitcoin
70,488.12
(
-1.06%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 200628

Monday, 10/17/2016 4:17:47 PM

Monday, October 17, 2016 4:17:47 PM

Post# of 257259
(JNJ)—PFE launching US Remicade FoB in November ~15% discount:

http://finance.yahoo.com/news/pfizer-announces-u-availability-biosimilar-200500747.html

INFLECTRA will be introduced at a 15% discount to the current wholesaler acquisition cost (WAC) of REMICADE, its reference product. WAC is not inclusive of discounts to payers, providers, distributors and other purchasing organizations.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today